These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26634886)

  • 1. Carotid artery thickness is associated with chronic use of highly active antiretroviral therapy in patients infected with human immunodeficiency virus: A 3.0 Tesla magnetic resonance imaging study.
    LaBounty TM; Hardy WD; Fan Z; Yumul R; Li D; Dharmakumar R; Conte AH
    HIV Med; 2016 Aug; 17(7):516-23. PubMed ID: 26634886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.
    Stein JH; Ribaudo HJ; Hodis HN; Brown TT; Tran TT; Yan M; Brodell EL; Kelesidis T; McComsey GA; Dube MP; Murphy RL; Currier JS
    AIDS; 2015 Sep; 29(14):1775-83. PubMed ID: 26372383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis is Evident in Treated HIV-Infected Subjects With Low Cardiovascular Risk by Carotid Cardiovascular Magnetic Resonance.
    Rose KA; Vera JH; Drivas P; Banya W; Keenan N; Pennell DJ; Winston A
    J Acquir Immune Defic Syndr; 2016 Apr; 71(5):514-21. PubMed ID: 26579986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.
    Lorenz MW; Stephan C; Harmjanz A; Staszewski S; Buehler A; Bickel M; von Kegler S; Ruhkamp D; Steinmetz H; Sitzer M
    Atherosclerosis; 2008 Feb; 196(2):720-6. PubMed ID: 17275008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children.
    McComsey GA; O'Riordan M; Hazen SL; El-Bejjani D; Bhatt S; Brennan ML; Storer N; Adell J; Nakamoto DA; Dogra V
    AIDS; 2007 May; 21(8):921-7. PubMed ID: 17457085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial stiffness and carotid intima-media thickness in HIV infected patients.
    Papita A; Albu A; Fodor D; Itu C; Cârstina D
    Med Ultrason; 2011 Jun; 13(2):127-34. PubMed ID: 21655539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
    Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
    Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased pericardial fat accumulation is associated with increased intramyocardial lipid content and duration of highly active antiretroviral therapy exposure in patients infected with human immunodeficiency virus: a 3T cardiovascular magnetic resonance feasibility study.
    Diaz-Zamudio M; Dey D; LaBounty T; Nelson M; Fan Z; Szczepaniak LS; Hsieh BP; Rajani R; Berman D; Li D; Dharmakumar R; Hardy WD; Conte AH
    J Cardiovasc Magn Reson; 2015 Oct; 17():91. PubMed ID: 26520571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.
    Ross AC; Rizk N; O'Riordan MA; Dogra V; El-Bejjani D; Storer N; Harrill D; Tungsiripat M; Adell J; McComsey GA
    Clin Infect Dis; 2009 Oct; 49(7):1119-27. PubMed ID: 19712036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors of vascular intima media thickness in HIV-positive subjects.
    Bongiovanni M; Casana M; Cicconi P; Pisacreta M; Codemo R; Pelucchi M; d'Arminio Monforte A; Bini T
    J Antimicrob Chemother; 2008 Jan; 61(1):195-9. PubMed ID: 17999980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Biomarkers and Carotid Thickness in HIV Infected Patients under Antiretroviral Therapy, Undetectable HIV-1 Viral Load, and Low Cardiovascular Risk.
    Leite KME; Santos Júnior GG; Godoi ETAM; Vasconcelos AF; Lorena VMB; Araújo PSR; Lima KO; Lacerda HR
    Arq Bras Cardiol; 2020 Jan; 114(1):90-97. PubMed ID: 31664319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.
    Johnsen S; Dolan SE; Fitch KV; Kanter JR; Hemphill LC; Connelly JM; Lees RS; Lee H; Grinspoon S
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4916-24. PubMed ID: 17003092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between the Framingham Risk Score and Carotid Artery Intima-Media Thickness in Patients With Human Immunodeficiency Virus.
    Sumayin Ngamdu K; Adewale OO; Mallawaarachchi I; Alozie OK; Dwivedi AK; Bhatt DL
    Am J Cardiol; 2020 Jul; 127():156-162. PubMed ID: 32466846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of first-line highly active antiretroviral therapy is not associated with carotid artery stiffness in human immunodeficiency virus-positive patients.
    Zhu H; Yuan J; Wang Y; Gao F; Wang X; Wei C; Chen J; Fan X; Zhang M
    Braz J Infect Dis; 2014; 18(5):496-500. PubMed ID: 24819160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
    Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adults.
    Vigano A; Bedogni G; Cerini C; Meroni L; Giacomet V; Stucchi S; Fabiano V; Coletto S; Catalano M; Minola M; Zuccotti GV
    Curr HIV Res; 2010 Jul; 8(5):411-7. PubMed ID: 20426755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection.
    Calza L; Verucchi G; Pocaterra D; Pavoni M; Alfieri A; Cicognani A; Manfredi R; Serra C; Chiodo F
    Int J STD AIDS; 2009 Oct; 20(10):683-9. PubMed ID: 19815912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac function in vertically HIV-infected children and adolescents in the era of highly active antiretroviral therapy.
    Sainz T; Álvarez-Fuente M; Fernández-Jiménez R; González-Tomé MI; de José MI; Ramos JT; Navarro ML; Martínez J; García-Hortelano M; Medrano C; Muñoz-Fernández MÁ; Mellado MJ;
    Pediatr Infect Dis J; 2015 May; 34(5):e125-31. PubMed ID: 25876103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.
    Kaplan RC; Landay AL; Hodis HN; Gange SJ; Norris PJ; Young M; Anastos K; Tien PC; Xue X; Lazar J; Parrinello CM; Benning L; Tracy RP
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):359-68. PubMed ID: 22592585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.